Melanoma is a cancer arising from cells in the body called melanocytes. As normal melanocytes mature they produce the pigment, melanin, which can determine features such as hair, eye and skin colour.
MRV Research
What molecular changes drive metastasis in melanoma?
When a melanoma that appears for the first time is localized and excised, it presents a low risk for the patient. But when this tumour decides to travel and deposit itself somewhere else in the body, it becomes a dangerous situation.
4-miRNA Signature Associated With PFS in Patients With Melanoma Receiving Ipilimumab
A 4-microRNA signature is significantly associated with progression-free survival in patients with advanced melanoma treated with neoadjuvant ipilimumab, a study presented at the American Association for Cancer Research (AACR) Annual Meeting 2016 has shown.
Early Negativization of BRAF V600 in cfDNA Linked to Excellent Prognosis in Melanoma
Patients with early negativization of BRAF V600 in tumor-derived circulating cell-free DNA (cfDNA) have excellent prognosis, which is comparable to those with negative BRAF in pretreatment cfDNA, according to a study presented at American Association for Cancer Research (AACR) Annual Meeting 2016.